Table 2.
Prevalence of Higher MIR Worry by Cancer Type
| Total with CA Type | Total with Higher MIR Worry Among CA Type |
||||
|---|---|---|---|---|---|
|
|
|
||||
| CA Type | na | Weighted %a | nb | Weighted %b | p-valuec |
|
|
|
|
|
||
| Lung | 13 | 3.1% | 8 | 75.8% | 0.029* |
| Head/neck | 12 | 3.5% | 6 | 67.9% | 0.098+ |
| Hodgkins | 10 | 4.8% | 5 | 67.5% | 0.164 |
| Non-Hodgkin | 10 | 2.8% | 5 | 64.6% | 0.083+ |
| Endometrial | 14 | 4.9% | 8 | 57.3% | 0.356 |
| Breast | 82 | 16.5% | 40 | 56.5% | 0.008* |
| Prostate | 60 | 13.2% | 22 | 39.9% | 0.830 |
| Skin | 138 | 31.7% | 50 | 39.4% | 0.650 |
| Other | 40 | 8.8% | 15 | 32.3% | 0.365 |
| Colon | 30 | 5.7% | 10 | 32.0% | 0.423 |
| Cervical | 43 | 11.1% | 14 | 26.6% | 0.105 |
| Bladder | 10 | 1.7% | 3 | 24.7% | 0.231 |
| Melanoma | 36 | 8.3% | 8 | 21.4% | 0.031* |
Abbreviations: CA, cancer; MIR, medical imaging radiation.
a
Unweighted frequency and weighted percent with the given cancer type among 443 respondents with a history of cancer (9 of the total 452 cancer survivors did not report a diagnosis).
b
Unweighted frequency and weighted percent with higher (i.e., “Some” or “A lot”) MIR worry among the respondents with the given cancer type. For reference the overall weighted percentage of cancer survivors with higher MIR worry was 42.4%.
c
Rao-Scott chi-square p-values. For p < 0.05, the proportion of survivors with higher MIR worry differed significantly between those with versus without a history of the given cancer type.
+
p < 0.10,
*
p < 0.05